Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.88 USD | -8.57% | -41.64% | -59.66% |
Business Summary
Number of employees: 25
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Eyecare & Wound Care
75.9
%
| 10 | 71.1 % | 11 | 75.9 % | +9.13% |
Skincare
24.1
%
| 4 | 28.9 % | 4 | 24.1 % | -14.72% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 14 | 100.0 % | 15 | 100.0 % | +2.24% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Justin Hall
CEO | Chief Executive Officer | 46 | 13-01-31 |
Tommy Law
DFI | Director of Finance/CFO | 38 | 19-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Freiman
CHM | Chairman | 89 | 02-04-30 |
Yen You Zheng
BRD | Director/Board Member | 67 | 19-09-10 |
Bob Wu
BRD | Director/Board Member | 49 | 16-01-25 |
Justin Hall
CEO | Chief Executive Officer | 46 | 13-01-31 |
Julie Garlikov
BRD | Director/Board Member | 53 | 22-01-26 |
Swan Sit
BRD | Director/Board Member | 46 | 19-12-16 |
Sean Zheng
BRD | Director/Board Member | 54 | 22-01-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,000 | 0 | 0 | 99.97 % |
Stock B | 1 | 1,151,715 | 1,151,399 ( 99.97 %) | 0 | |
Stock C | 0 | 1,000 | 0 | 0 |
Company contact information
NovaBay Pharmaceuticals, Inc.
2000 Powell Street Suite 1150
94608-1866, Emeryville
+510 899 8800
http://www.novabay.comSector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.66% | 3.32M | |
+46.19% | 55.7B | |
+40.12% | 39.91B | |
-6.14% | 39.57B | |
-6.65% | 28.16B | |
+12.33% | 26.3B | |
-21.78% | 18.94B | |
+28.38% | 12.17B | |
+24.18% | 12.12B | |
-0.35% | 12.12B |
- Stock Market
- Equities
- NBY Stock
- Company NovaBay Pharmaceuticals, Inc.